NCT04311320

Brief Summary

Purpose: Using a novel oxygen blender prototype with modified bCPAP to manage children 1 month to 5 years of age hospitalized with respiratory distress due to lower respiratory tract infection (LRTI) in low-resource settings is not associated with clinical failure within 1 hour of use. Aim: To investigate if this novel oxygen blender is safe to use among children 1 month to 5 years old hospitalized for respiratory distress from lower respiratory tract infections in a low-resource setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 17, 2020

Completed
2 years until next milestone

Study Start

First participant enrolled

March 26, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2023

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

April 15, 2024

Status Verified

April 1, 2024

Enrollment Period

1 year

First QC Date

March 5, 2020

Last Update Submit

April 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility as Measured by Clinical Failure

    The primary outcome of this study is the feasibility of the investigational device as measured by clinical failure within 1 hour of installing the blender in the bubble continuous positive airway pressure (bCPAP) circuit. Clinical failure is defined as the occurrence of any of the following patient events: intubation, death, or transfer for higher level of care, or any 2 of the following events; \<85% O2 saturation after 30 min of treatment, new signs of respiratory distress, or partial pressure of carbon dioxide greater than 60 mmHg and pH less than 7.2 in capillary blood gas. Outcome will be reported as the percent of participants who experience clinical failure within 1 hour after blender installation.

    1 hour

Secondary Outcomes (9)

  • Oxygen Saturation

    Approximately 7 days

  • Oxygen Concentration of Outflow

    Approximately 7 days

  • Flow of Oxygen from Tank

    Approximately 7 days

  • Continuous Positive Air Pressure (CPAP) Level

    Approximately 7 days

  • Bubble Continuous Positive Air Pressure (bCPAP) Maintenance

    Approximately 7 days

  • +4 more secondary outcomes

Study Arms (1)

Low-Resource Oxygen Blender

EXPERIMENTAL

This is a single-arm study. All participants will receive respiratory support using the investigational device.

Device: Low-Resource Oxygen Blender

Interventions

The device that is being evaluated is a novel low-cost, high access oxygen blender designed to be used in the World Health Organization bCPAP design. It functions by utilizing the Venturi effect, whereby a narrow jet of one fluid (i.e. oxygen) creates a suction effect and entrains surrounding ambient fluid (i.e. room air) into the jet, effectively creating a mixed solution of both fluids. The cost of materials amounts to approximately 1.40 U.S.D. The average time it takes to build a blender and incorporate it into a bCPAP circuit for a new user is approximately 16 minutes. The materials can all be found in a standard hospital, namely 3cc syringes with rubber stops and a 22 gauge hypodermic needle.

Low-Resource Oxygen Blender

Eligibility Criteria

Age0 Days - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Admitted for lung disease and require hospitalization
  • Admission diagnosis is lower respiratory tract infection or pneumonia or bronchiolitis (any infectious microbe including bacterial, viral, fungal, parasitic)
  • Have respiratory distress on presentation to the hospital (cough or trouble breathing plus at least one of the following: \<92% despite low flow oxygen, central cyanosis, tachypnea, chest indrawing, nasal flaring, grunting, head nodding, convulsions, lethargy, inability to breastfeed or drink)
  • A bCPAP (electronic) machine is not available to use

You may not qualify if:

  • History of asthma
  • Upper airway obstruction
  • Diaphragmatic hernia
  • Pneumothorax
  • Acute Glasgow Coma score \<4
  • Cleft Palate
  • Cyanotic heart disease
  • Bleeding disorders
  • Imminent death within 2 hours
  • Have had abdominal or thoracic surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chenla Children's Healthcare

Kratié, Kratié Province, 10109, Cambodia

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Andrew Wu, MD, MPH

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2020

First Posted

March 17, 2020

Study Start

March 26, 2022

Primary Completion

March 28, 2023

Study Completion

December 31, 2023

Last Updated

April 15, 2024

Record last verified: 2024-04

Locations